Stock Earnings
Analysts review Summit Therapeutics Inc’s rating
Summit Therapeutics Inc’s recently made public that its Chief Executive Officer Zanganeh Mahkam acquired Company’s shares for reported $0.2 million
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.